Medicus Pharma Ltd. Common Stock (MDCX) vs Valion Bio, Inc. (VBIO)

A side-by-side comparison of Medicus Pharma Ltd. Common Stock and Valion Bio, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare
Medicus Pharma Ltd. Common Stock logo
MDCX
Medicus Pharma Ltd. Common Stock
$10M
$0.16HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
Valion Bio, Inc. logo
VBIO
Valion Bio, Inc.
$10M
$2.38HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT

Total return — MDCX vs VBIO

growth of $100 · dividends reinvested · last 2y
MDCX -93.7% (-74.9%/yr)VBIO -98.4% (-87.4%/yr)MDCX compounded faster over this window
0100200300Start $10020252026$6$2
MDCX VBIO

MDCX vs VBIO: by the numbers

  • •MDCX is the larger company ($10M vs $10M market cap).

Metrics side by side

Valuation

MetricMDCXVBIO
P/B ratioN/A2.32

Profitability

MetricMDCXVBIO
Gross margin0.00%0.00%
Operating margin0.00%0.00%
Net margin0.00%0.00%
ROEN/A-157.76%
ROIC-269.16%-55.13%

Go deeper

Full MDCX analysisFull VBIO analysisInteractive comparison tool

Dig into the metrics

Medicus Pharma Ltd. Common Stock ROEValion Bio ROEMedicus Pharma Ltd. Common Stock operating marginValion Bio operating marginMedicus Pharma Ltd. Common Stock revenue growthValion Bio revenue growthMedicus Pharma Ltd. Common Stock free cash flowValion Bio free cash flow

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.